bioRxiv2026
Methylmalonylation is a non-enzymatic lysine post-translational modification derived from methylmalonyl-CoA, a reactive intermediate that accumulates during mitochondrial dysfunction and branched-chain amino acid catabolism. Although reported in models of methylmalonic acidemia, its broader distribution and functional relevance remain largely unexplored. Progress has been hindered by a key analytical challenge: methylmalonyl-and succinyl-lysine are isobaric (+100.0160 Da) and generate overlapping mass spectrometric fragmentation spectra, preventing confident identification in conventional proteomic workflows. Here, we establish a straightforward proteomic workflow that overcomes this barrier and enables confident identification and quantification of lysine methylmalonylation by combining antibody-based enrichment with data-independent acquisition mass spectrometry (DIA-MS). Anti-malonyl antibodies were used to enrich methylmalonylated peptides through cross-reactivity. Using synthetic peptide standards containing malonyl-, succinyl-, or methylmalonyl-lysine, we defined distinguishing analytical features including chromatographic retention time, ion mobility, and fragmentation patterns. Applying this approach to mouse brain tissues from Sirtuin-5 (SIRT5) knockout and wild-type mice, we identified 44 methylmalonylated peptides across 41 proteins, enriched in neuronal and myelin-associated proteins (NEFM, NEFL, MBP) and mitochondrial enzymes such as ADT1. Several sites were increased in SIRT5-deficient brains, consistent with regulation by this mitochondrial deacylase. Functional assays demonstrated that methylmalonylation of myelin basic protein (MBP) impairs lipid binding, linking this modification to myelin stability. Together, this workflow enables confident methylmalonylation identification and defines it as a widespread and regulated modification in the brain, providing a framework to study metabolically driven protein acylation in neurobiology and disease. SignificanceLysine methylmalonylation has remained largely unexplored due to its isobaric overlap with succinylation, which prevents confident identification using conventional proteomic workflows. Here, we establish an integrated strategy combining antibody-based enrichment, data-independent acquisition mass spectrometry, and orthogonal analytical features to resolve these modifications with high confidence. Applying this approach to mouse brain tissue reveals a SIRT5-regulated methylmalonylome enriched in mitochondrial and myelin-associated proteins, including myelin basic protein (MBP). Functional assays demonstrate that methylmalonylation impairs MBP lipid binding, linking this modification to myelin stability. Beyond this specific application, our workflow provides a generalizable framework to resolve isobaric post-translational modifications and expands the study of metabolically driven protein acylation in neurobiology and disease.